Bureau Veritas Strengthens Its Positioning in Luxury and Fashion Through the Acquisition of LBS Group
Bureau Veritas, a global leader in Testing, Inspection, and Certification services, announces the acquisition of LBS Luxury Brands Services S.R.L. Group, a leader in quality assurance and quality control in the luxury industry. This acquisition is in line with Bureau Veritas’ LEAP | 28 strategy to strengthen its positioning and offering in the luxury and fashion industries while reinforcing its supply chain solutions as well as its presence in the Italian market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241202474125/en/
Hinda Gharbi, CEO Bureau Veritas (Photo: Business Wire)
The acquisition of LBS Group marks a milestone for Bureau Veritas' Consumer Products Services division, as it strengthens its presence in upstream services, augmenting its capacity to deliver supply chain quality and sustainability services. It is a key move that adds new expertise to Bureau Veritas portfolio in the accessories segment and establishes the Group as a premier end-to-end service provider for high-end fashion brands.
Since its establishment in 2013, LBS Group has become a strategic partner for top premium and luxury brands. The Company provides both laboratory and upstream supply chain quality management services, with recognized expertise in the accessories metal hardware segment as well as in raw material and finished products. Known for its innovative sustainability solutions, LBS optimizes quality and eliminates finished product defects through process improvements at its clients’ production sites. The company, headquartered in Italy, delivered revenues of €8.8 million in 2023 through its network of over 100 specialists located near production hubs in Europe.
Hinda Gharbi, Chief Executive Officer of Bureau Veritas, commented: “M&A is an essential component of Bureau Veritas’ LEAP | 28 strategy. With the acquisition of LBS Group, Bureau Veritas has closed 10 acquisitions since the beginning of the year. LBS Group’s capabilities in quality assurance strengthen our presence in upstream services for the luxury sector. It positions Bureau Veritas as a preferred partner in the luxury industry assurance market for the world's leading brands. I am delighted to welcome all our new colleagues from LBS Group to Bureau Veritas.”
Luca Cartocci, LBS Group CEO and Founder, added: "All our team members are honored to join Bureau Veritas’ global network, which is well positioned for growth into the luxury segment with huge market potential to expand our unique and innovative solutions as well as our shared values of integrity and high level of service delivery. Joining forces with Bureau Veritas will create a global integrated platform experience that can flexibly and expertly assist the fashion industry in the Premium and Luxury segments in corporate compliance, global market access, supply chain compliance, production quality assurance and quality control, as well as solutions and consulting on process and product sustainability.”
About Bureau Veritas
Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress.
With a vision to be the preferred partner for its customers’ excellence and sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 83,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us on LinkedIn.
About LBS Luxury Brands Services S.R.L. Group
LBS is a laboratory specializing in quality control for products in the fashion industry, from leather goods to footwear. It stands out from the competition, providing clients with qualitative and procedural expertise in test results. LBS uses state-of-the-art instrumentation to perform chemical and toxicological analysis on product materials, assessing the impact on the environment and consumer health, and conducts physical-mechanical tests to evaluate product performance. LBS was founded in 2013 with the need to make tertiary some industrial experiences in the field of quality related to the world of leather goods, footwear and bijoux, with specific references to the metal accessory.
For more information, visit https://luxurybrandservices.it/ and follow us on Linkedin.
Our information is certified with blockchain technology.
Check that this press release is genuine at www.wiztrust.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241202474125/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom